Pilot Study of Allergy Immunotherapy and Prevention of Viral Respiratory Infections
|Allergy Seasonal Allergic Rhinitis Perennial Allergic Rhinitis|
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Pilot Study of Allergy Immunotherapy and Prevention of Viral Respiratory Infections|
|Study Start Date:||October 2006|
|Study Completion Date:||December 2009|
Patients starting immunotherapy
Patients being treated using methods other than immunotherapy
This study will consist of five visits. Visit 1 will occur after subjects complete an initial clinical evaluation for allergy at this site. Subjects will select their treatment (allergy immunotherapy as compared to standard medical care) prior to enrollment in this study.
Visit 1 will include informed consent, review of inclusion and exclusion criteria and phlebotomy for the determination of serum interferon-gamma levels. At the end of this visit, diary cards to capture the frequency of symptoms of viral respiratory infections will be distributed. Visits 2-5 will occur 3, 6, 9 and 12 months after visit 1 and will include review/exchange of diary cards, and phlebotomy for determination of serial serum interferon-gamma levels.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00405899
|United States, Pennsylvania|
|Allegheny General Hospital|
|Pittsburgh, Pennsylvania, United States, 15212|
|Principal Investigator:||Deborah Gentile, MD||West Penn Allegheny Health System|